CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Insiders were net buyers of CRISPR Therapeutics AG's (NASDAQ:CRSP ) stock during the past year. That is, insiders bought more stock than they sold. Although we don't think shareholders should simply ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

Crispr Therapeutics said Chief Operating Officer Julianne Bruno would depart the company to pursue other opportunities, effective April 11. Bruno joined the gene-editing company in 2019 and stepped ...

Focused on curing diseases like Alzheimer’s, Parkinson’s, and Huntington’s, Mammoth is advancing CRISPR beyond blood disorders to target the brain, muscle, and heart.

Avantax Advisory Services Inc. acquired a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock Research Institute (ILRI) have developed a reverse genetics system for ...

He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease.

The global CAR T-cell therapy market is projected to grow from USD 2.7 billion in 2025 to over USD 27.5 billion by 2033, reflecting a robust CAGR of 26.2%.

From the fall of the Soviet Union to the rise of Amazon, the 90s reshaped our world in profound ways. Join us as we count down the decade's most transformative events that continue to influence our ...

Duke professor Pranam Chatterjee discusses AI in biology, advocating for sequence-based over structure-based protein models, ...